Skip to content
healthcare.dev

EGRIFTA SV

NDC 62064-241, tesamorelin, kit, from Theratechnologies Inc..

Product NDC
62064-241
Status
Listed
Labeler
Theratechnologies Inc.
Dosage form
KIT
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022505
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62064-241 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
62064-241-30620640241301 KIT in 1 BOX (62064-241-30) * .5 mL in 1 VIAL * 30 BOTTLE in 1 TRAY / 10 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3d783378-b02d-4f19-99dd-0fc91a042224

Use it

Look up 62064-241 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62064-241 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62064-241. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.